MALAT1 | Alzheimer’s disease | Cell model: PC12 cells are terated with NGF; animal model: SD rats are injected with Aβ1-42 | Down | Anti-inflammatory | miR-125b/PTGS2,CDK5, FOXQ1 | Inhibiting neuron apoptosis and neuroinflammation; stimulating neurite outgrowth | Ma et al., 2019 |
Parkinson’s disease | Cell model: BV2 and N2a cells are treated with LPS; animal model: C57BL/6 mice are injected with MPTP-hydrochloride | Up | Pro-inflammatory | EZH2-NRF2 | Promoting inflammasome activation and reactive oxygen species production; shortening the movement time | Cai et al., 2020b |
Traumatic brain injury | Animal model: male rats' brains are impacted at the frontoparietal cortex reaching a depth of 0.5 mm below the dura matter layer | Up (by hASC-derived exosomes) | Anti-inflammatory | The microRNAs and the small nucleolar RNAs | Recovering motor behavior function; reducing cortical brain injury | Patel et al., 2018 |
Acute spinal cord injury | Animal model: a 10g weight drop from a 2.5-cm height on a T10 spinal cord of the SD rat | Up | Pro-inflammatory | miR-199b/ IKKβ/ NF-κB | Promoting microglia activation and neuroinflammation; destroying the hindlimb locomotor activity | Zhou et al., 2018a |
Ischemic stroke | Cell model: rBMVEC cells are placed in an oxygen and glucose deprivation condition and reperfusion; animal model: SD rats are subjected to transient middle cerebral artery occlusion | Up (by polydatin) | Anti-inflammatory | C/EBPβ/MALAT1/CREB/PGC-1α/PPARγ | Protecting brain microvascular integrity and ameliorating stroke | Ruan et al., 2019 |
Multiple sclerosis | Cell model: primary macrophages and splenocytes are treated with LPS; animal model: C57BL/6 mice are injected with MOG35–55/CFA | Down | Anti-inflammatory | None | Promoting the pattern of macrophage and T cell differentiation toward anti-inflammatory phenotype | Masoumi et al., 2019 |
Neuropathic pain | Animal model: the bilateral sciatic nerves of SD rats are ligated | Up | Pro-inflammatory | miR-129-5p/HMGB1 | Promoting the development of neuropathic pain and neuroinflammation | Ma et al., 2020b |
Neuropathic pain | Animal model: the bilateral sciatic nerves of SD rats are ligated | Up | Pro-inflammatory | miR-206/ZEB2 | Promoting the development of neuropathic pain and neuroinflammation | Chen et al., 2019b |
Neuropathic pain | Animal model: the bilateral sciatic nerves of SD rats are ligated | Up | Pro-inflammatory | miR-154-5p/AQp9 | Promoting the development of neuropathic pain and neuroinflammation | Wu et al., 2020b |
NEAT1 | Parkinson’s disease | Cell model: SK-N-SH cells are treated with MPP+; animal model: C57BL/6 mice are injected with MPTP | Up | Pro-inflammatory | miR-212-3p/AX1N1 | Promoting apoptosis and inflammation; inhibiting cell viability | Liu et al., 2021d |
Parkinson’s disease | Cell model: SK-N-SH cells are treated with MPP+ | Up | Pro-inflammatory | miR-212-5p/RAB3IP | Promoting apoptosis and inflammation | Liu et al., 2020c |
Neuropathic pain | Animal model: the bilateral sciatic nerves of SD rats are ligated | Up | Pro-inflammatory | miR-381/HMGB1 | Promoting the development of neuropathic pain and neuroinflammation | Xia et al., 2018 |
Epilepsy | Cell model: CTX-TNA cells are treated with IL-1β | Up | Pro-inflammatory | miR-129-5p/Notch | Promoting inflammation; inhibiting cell viability | Wan and Yang, 2020 |
Ischemic stroke | Cell model: microglia cells are placed in an oxygen and glucose deprivation condition and reperfusion | Up (by YY1) | Pro-inflammatory | YY1/NEAT1/Wnt/β-catenin | Promoting inflammation and apoptosis of microglial cells | Han and Zhou, 2019 |
Traumatic brain injury | Animal model: C57BL/6 mice' brains are impacted at the frontoparietal cortex reaching a depth of 0.5 mm below the dura matter layer | Up (by bexarotene) | Anti-inflammatory | Bexarotene/RXR-α/ NEAT1/PIDD1 | Inhibiting apoptosis and inflammation | Zhong et al., 2017 |
Cerebral ischemic reperfusion | Cell model: BV2 cells are placed in an oxygen and glucose deprivation condition and reperfusion | Up | Anti-inflammatory | AKT/STAT3 | Promoting cell viability; inhibiting microglial M1 polarization and cell apoptosis | Ni et al., 2020 |
TUG1 | Parkinson’s disease | Cell model: BV2 cells are treated with LPS; animal model: C57/BL mice are injected with MPTP | Up | Pro-inflammatory | None | Promoting inflammation of BV2 cell and inhibiting motor coordination ability of PD mice | Cheng et al., 2021 |
Parkinson’s disease | Cell model: SH-SY5Y cells are treated with MPP+; animal model: C57BL/6 mice are injected with MPTP | Up | Pro-inflammatory | miR-152-3p/PTEN | Promoting apoptosis and inflammation and oxidative stress | Zhai et al., 2020 |
Multiple sclerosis | Cell model: BV2 cells are treated with LPS; animal model: C57BL/6 mice are injected with MOG35–55 | Up | Pro-inflammatory | miR-9-5p/NF-κB1 | Promoting inflammation | Yue et al., 2019 |
Ischemic stroke | Cell model: BV2 cells are placed in an oxygen and glucose deprivation condition and reperfusion | Up | Pro-inflammatory | miR-145a-5p/NF-κB | Promoting microglial M1 polarization and neuroinflammation | Wang et al., 2019a |
Spinal cord ischemia reperfusion | Animal model: the descending aorta is cross-clamped distal to the left subclavian artery of the SD rat for 14 minutes; the clamp is removed and reperfusion is continued | Up | Pro-inflammatory | miR-29b-1-5p/MTDH/ NF-κB/IL-1β | Promoting inflammation damage (neurologic defects and blood-spinal cord barrier leakage) | Jia et al., 2021 |
Spinal cord ischemia reperfusion | Animal model: the descending aorta is cross-clamped distal to the left subclavian artery of the SD rat for 14 minutes; the clamp is removed and reperfusion is continued. | Up | Pro-inflammatory | TRIL/TLR4/NF-κB/IL-1β | Promoting microglial activation and inflammation damage (neurologic deficit and blood-spinal cord barrier leakage) | Jia et al., 2019 |
SNHG family | Ischemic stroke | Cell model: HCMEC/D3 cells are placed in an oxygen and glucose deprivation condition and reperfusion | Down | Anti-inflammatory | miR-376a/CBS/H2S | Inhibiting apoptosis and inflammation | Lv et al., 2021b |
Parkinson’s disease | Cell model: BV2 cells are treated with LPS; animal model: C57BL/6 mice are injected with MPTP-HCL | Up | Pro-inflammatory | miR-7/NLRP3 | Promoting microglial activation and inflammation; promoting primary dopaminergic neurons apoptosis | Cao et al., 2018 |
Neuropathic pain | Animal model: the fifth lumbar spinal nerve of the SD rat is isolated and ligated using 6-0 silk suture | Up | Pro-inflammatory | CDK4 | Promoting neuroinflammation and neuropathic pain progression | Zhang et al., 2020b |
Neuropathic pain | Animal model: the fifth lumbar spinal nerve of SD rat is isolated and ligated using 6-0 silk suture | Up | Pro-inflammatory | miR-423-5p | Promoting neuroinflammation and neuropathic pain progression | Pan et al., 2020 |
Ischemic stroke | Cell model: primary microglial cells are placed in an oxygen and glucose deprivation condition and reperfusion; animal model: SD rats are subjected to transient middle cerebral artery occlusion and reperfusion | Down | Anti-inflammatory | miR-425-5p/SIRT1/NF-κB | Inhibiting microglial inflammation and BMECs injury | Tian et al., 2021 |
Ischemic stroke | Cell model: BV2 cells are placed in an oxygen and glucose deprivation condition and reperfusion; animal model: C57BL/6 mice are subjected to transient middle cerebral artery occlusion and reperfusion | Up | Pro-inflammatory | miR-199b/AQP4 | Promoting inflammation and oxidative stress of BV2; inhibiting cell viability | Zhang et al., 2021b |
Ischemic stroke | Cell model: PC12 cells are placed in an oxygen and glucose deprivation condition and reperfusion | Up | Pro-inflammatory | miR-455-3p/TP53INP1 | Promoting inflammation, apoptosis, and oxidative stress of PC12; inhibiting cell viability | Fan et al., 2021 |
H19 | Spinal cord injury | Cell model: BV2 cells are treated with LPS; animal model: the dural sac of BALB/c mice is combated | Up | Pro-inflammatory | miR-325-3p/NEUROD4 | Up apoptosis and inflammation of BV2 cells | Gu et al., 2021 |
Temporal lobe epilepsy | Animal model: the intra-amygdala of the SD rat is injected with KA | Up | Pro-inflammatory | JAK/STAT | Promoting activation of astrocytes and microglia and inflammation | Han et al., 2018 |
Ischemic stroke | Cell model: BV2 cells are placed in an oxygen and glucose deprivation condition and reperfusion; animal model: C57BL/6 mice are subjected to transient middle cerebral artery occlusion and reperfusion | Up | Pro-inflammatory | HDAC1 | Promoting M1 microglial polarization and inflammation | Wang et al., 2017a |
MEG3 | Cerebral ischemia reperfusion | Cell model: SK-N-SH and SH-SY5Y cells are placed in an oxygen and glucose deprivation condition and reperfusion; animal model: SD rats are subjected to transient middle cerebral artery occlusion and reperfusion | Up | Pro-inflammatory | miR-485/AIM2 | Promoting SK-N-SH and SH-SY5Y cells pyroptosis and inflammation | Liang et al., 2020 |
Traumatic brain injury | Cell model: microglia cells are treated with LPS+ATP | Up | Pro-inflammatory | miR-7a-5p/NLRP3 | Promoting microglial activation and inflammation | Meng et al., 2021 |
Alzheimer's disease | Animal model: the right ventricl of SD rat is injected with Aβ25-35 | Down | Anti-inflammatory | PI3K/AKT | Improving cognitive impairment; alleviating neuronal damage; inhibiting activation of astrocytes | Yi et al., 2019 |
XIST | Epilepsy | Cell model: CTX-TNA2 astrocyte cells are treated with LPS; animal model: SD rats are injected with pentylenetetrazol | Up | Pro-inflammatory | miR-29c-3p/NFAT5 | Promoting neuronal apoptosis and glutamate accumulation | Zhang et al., 2021c |
Neuropathic pain | Animal model: the bilateral sciatic nerves of SD rats are ligated | Up | Pro-inflammatory | miR-544 /STAT3 | Promoting the development of neuropathic pain and neuroinflammation | Jin et al., 2018b |
Neuropathic pain | Animal model: the bilateral sciatic nerves of SD rats are ligated | Up | Pro-inflammatory | miR-150/ZEB1 | Promoting the development of neuropathic pain and neuroinflammation | Yan et al., 2018 |
GAS5 | Parkinson’s disease | Cell model: microglia cells are treated with LPS; animal model: C57BL/6 mice are injected with rotenone | Up | Pro-inflammatory | miR-223-3p/NLRP3 | Promoting microglial inflammation | Xu et al., 2020 |
Spinal cord ischemia reperfusion | Animal model: the aortic arch is clamping distal to the left subclavian artery and left carotid artery of the SD rat; the clamp is removed and reperfusion is continued | Up | Pro-inflammatory | MMP-7/cleaved caspase-3 | Promoting apotosis and inflammation; aggravating functional impairment | Zhang et al., 2021d |
Multiple sclerosis | Animal model: C57BL/6 mice are injected with MOG35-55 and Pertussis toxin in PBS | Up | Pro-inflammatory | PRC2/IRF4 | Inhibiting microglial M2 polarization; exacerbating demyelination | Sun et al., 2017 |
UCA1 | Epilepsy | Cell model: CTX-TNA2 cells are treated with IL-1β; animal model: SD rats are injected with pilocarpine hydrochloride | Down | Anti-inflammatory | miR-203/MEF2C/NF-κB | Inhibiting inflammation; improving CTX-TNA2 cells viability | Yu et al., 2020b |
Parkinson’s disease | Animal model: the medial forebrain bundle of the Wistar rat is injected with 6-OHDA | Up | Pro-inflammatory | PI3K/AKT | Promoting dopaminergic neurons apoptosis, oxidative stress and inflammation | Cai et al., 2019 |
GM4419 | Ischemic stroke | Cell model: primary microglial cells are placed in an oxygen and glucose deprivation condition and reperfusion | Up | Pro-inflammatory | IkBa/NFκB | Promoting microglial cell death and necrosis | Wen et al., 2017 |
Traumatic brain injury | Cell model: primary mouse astrocytes are mechanically stretch-injured using 94A Cell Injury Controller | Up | Pro-inflammatory | miR-466l/TNF-a | Promoting astrocyte apoptosis | Yu et al., 2017 |